Cite
APA Citation
Guerenne, L., Beurlet, S., Said, M., Gorombei, P., Le Pogam, C., Guidez, F., de la Grange, P., Omidvar, N., Vanneaux, V., Mills, K., Mufti, G., Sarda-Mantel, L., Noguera, M., Pla, M., Fenaux, P., Padua, R., Chomienne, C., & Krief, P. (2016). gEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of hematology & oncology, 9(1), 1–20. http://access.bl.uk/ark:/81055/vdc_100080426339.0x0000c6